Mirzotamab is a naked IgG1kappa monoclonal antibody targeting the immune checkpoint protein CD276/B7-H3. As the unconjugated form of Mirzotamab clezutoclax, it is a key research tool for investigating B7-H3 function in oncology and immunology through in vitro binding assays and in vivo model studies.
Konzentration:
16.85 mg/mL
Molekulargewicht:
145 kDa
Reinheit:
99.45% (May vary between batches)
CAS Nummer:
[2229859-11-2]
Target-Kategorie:
ADC Antibody,Immunology/Inflammation related,B7
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten